Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Continuous monitoring of glucose for Type 1 Diabetes: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series; 18(2). 2018 Authors' conclusions Continuous glucose monitoring was more effective than self-monitoring of blood glucose in
managing type 1 diabetes for some outcomes, such as time spent in the target glucose range and
time spent outside the target glucose range (moderate certainty in this evidence). We were less
certain that continuous glucose monitoring would reduce the number of severe hypoglycemic
events. Compared with self-monitoring of blood glucose, the costs of continuous glucose monitoring
were higher, with only small increases in health benefits. Publicly funding continuous glucose
monitoring for the type 1 diabetes population in Ontario would result in additional costs to the health
system over the next 5 years. Adult patients and parents of children with type 1 diabetes reported
very positive experiences with continuous glucose monitoring. The high ongoing cost of continuous
glucose monitoring devices was seen as the greatest barrier to their widespread use. Indexing Status Subject indexing assigned by CRD MeSH Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Glucose; Humans; Technology Assessment, Biomedical Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca AccessionNumber 32018000187 Date abstract record published 16/04/2018 |